Zobrazeno 71 - 80
of 238
pro vyhledávání: '"Marc Espié"'
Autor:
A. Monnier, D. Serin, Anne-Claire Hardy-Bessard, Marc Espié, Alain Lortholary, Marie-Aude Coulon Sfairi, Maria Pavlyuk, Remy Delva, Leila Kockler, Xavier Pivot, Jean-Yves Pierga, Corinne Veyret, Florence Dalenc
Publikováno v:
Bulletin du Cancer. 99:609-618
The efficacy of the combination bevacizumab-chemotherapy in the first-line treatment of metastatic breast cancer (mBC) was demonstrated in several randomized clinical trials. However, limited safety data is available in daily medical practice. ATHENA
Autor:
Jungsil Ro, Pirkko-Liisa Kellokumpu-Lehtinen, Sara A. Hurvitz, Javier Cortes, Flavien Roux, Heikki Joensuu, Jérôme Barrière, Joohyuk Sohn, Sung Bae Kim, Thomas Bachelot, Marc Espié, Mahmoud Ould-Kaci, Federico Piacentini, Andreas Schneeweiss, Petri Bono, Julie Taguchi, Jean-Marc Nabholtz, Emilie Le Rhun, Eva Ciruelos, Véronique Diéras
Publikováno v:
The Lancet Oncology
The Lancet Oncology, 2015, 16 (16), pp.1700-1710. ⟨10.1016/S1470-2045(15)00373-3⟩
Lancet Oncology
Lancet Oncology, 2015, 16 (16), pp.1700-1710. ⟨10.1016/S1470-2045(15)00373-3⟩
The Lancet Oncology, 2015, 16 (16), pp.1700-1710. ⟨10.1016/S1470-2045(15)00373-3⟩
Lancet Oncology
Lancet Oncology, 2015, 16 (16), pp.1700-1710. ⟨10.1016/S1470-2045(15)00373-3⟩
Summary Background Patients with advanced HER2-positive breast cancer frequently develop CNS metastases. The metastases that progress after brain radiotherapy and HER2-targeted systemic therapy are a difficult therapeutic challenge. We aimed to asses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02946e8acaa040b3cf84f31051bb51bf
https://hal.archives-ouvertes.fr/hal-02939614
https://hal.archives-ouvertes.fr/hal-02939614
Autor:
Laurence Cahen-Doidy, Naila Taright, Sophie Michaud, Luis Augusto Teixeira, Sophie Guillerm, E. Bourstyn, Laurent Quero, Christophe Hennequin, Marc Espié
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 122(1)
Purpose Breast conserving treatment, consisting of lumpectomy followed by whole-breast irradiation, is considered the standard of care in early-stage breast cancer. Randomized studies have reported that delivering boost doses to tumor bed improves lo
Autor:
Raphaël Porcher, Marc Espié, Caroline Cuvier, Roquancourt A De, Sylvie Giacchetti, A S Hamy, H Gronier
Publikováno v:
Cancer Research. 71:P4-10
Background Use of hormone replacement therapy (HRT) has been associated with increased risk of breast cancer. However relations between use of HRT and benign breast lesions remain contradictory (1-3). Our goal was to investigate whether HRT and its d
Autor:
Marc Delord, Elif Hindié, L Vercellino, Sylvie Giacchetti, M-E Toubert, Marc Espié, J-L Misset, A S Hamy, N. Berenger, D. Groheux
Publikováno v:
Cancer Research. 71:P2-09
Background: Prospective evaluation of the role of 18FDG-PET/CT in patients with large primary operable breast cancer. Material and Methods: During 56 months, consecutive patients with large (>2cm) breast cancer and clinical stage IIA/IIB/IIIA (based
Autor:
Sylvie Giacchetti, Jean-Louis Misset, David Groheux, Anne-Sophie Hamy, Marie-Elisabeth Toubert, Marc Espié, Nathalie Berenger, Marc Delord, Elif Hindié, Laetitia Vercellino
Publikováno v:
Journal of Nuclear Medicine. 52:1526-1534
The purpose of this study was to prospectively evaluate the role of 18F-FDG PET/CT in patients with stage IIA, IIB, or IIIA breast cancer. Methods: During 56 mo, 131 consecutive patients with large (>2 cm) breast cancer and clinical stage IIA, IIB, o
Autor:
Jean-Yves Pierga, Marie-Christine Etienne-Grimaldi, Patricia Formento, Mireille Francoual, Gérard Milano, Florence Dalenc, A. Degeorges, Rémi Delva, Xavier Pivot, Marc Espié, Corinne Veyret, Patricia de Cremoux, Jean-Louis Formento, Magali Piutti
Publikováno v:
British Journal of Clinical Pharmacology. 71:921-928
AIMS To test prospectively the impact of VEGF-A gene polymorphisms on the pharmacodynamics of bevacizumab-chemotherapy in breast cancer patients.
Autor:
Hany Soliman, Sylvie Giacchetti, Jacqueline Lehmann-Che, E. Bourstyn, Luc Legrès, Elisabeth Turpin, F Amira-Bouhidel, Philippe Bertheau, Marc Espié, A de Roquancourt, C. de Bazelaire, L-F Plassa, Martine Antoine, E Flandre, Mariana Varna, R Bernoud, C Bocquet, Laurence Cahen-Doidy, Anne Janin
Publikováno v:
British Journal of Cancer
Background: Immunohistochemistry (IHC) and fluorescent in situ hybridisation (FISH) are currently the most commonly used methods to assess HER2 status. PCR-based assays allow quantitative determination of HER2 amplification (Q-PCR) or overexpression
Autor:
Martine Castro, Charles Coutant, J. Grenier, Johanna Arvis, Thierry Petit, Anne-Claire Hardy-Bessard, William Jacot, Roman Rouzier, David G. Cox, Thomas Bachelot, François-Clément Bidard, Mario Campone, Gérard Ganem, Marc Debled, Patrick Arveux, Jean-Philippe Jacquin, Suzette Delaloge, Alain Lortholary, Jérôme Lemonnier, Christelle Levy, Hugues Bourgeois, Etienne Brain, Anne Tardivon, Fabrice Andre, Hervé Bonnefoi, David Azria, Frédérique Penault-Llorca, Corinne Balleyguier, Laurence Venat-Bouvet, Marc Espié, Bernard Asselain, Florence Dalenc, Anthony Gonçalves, Joseph Gligorov, Bruno Coudert
Publikováno v:
Bulletin du Cancer. 103:951-952
Publikováno v:
Cancer Research. 70:P1-11
Introduction: Neoadjuvant chemotherapy is a standard of care in locally advanced breast carcinomas. The major purpose of neoadjuvant chemotherapy is breast conserving surgery. Advantages in survival have only been shown in patients undergoing achievi